检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:张斌[1] 解静荣[1] 朱海鹏[1] 张国峰[1]
机构地区:[1]新疆克拉玛依市中心医院血液肿瘤科,834000
出 处:《中国感染与化疗杂志》2012年第6期443-445,共3页Chinese Journal of Infection and Chemotherapy
摘 要:目的调查恶性肿瘤患者多重耐药菌医院感染的情况,为临床合理用药,降低和控制多重耐药菌感染提供依据。方法采用回顾性调查方法,对克拉玛依市中心医院2007年1月—2010年12月收治恶性肿瘤患者的医院感染情况进行调查,筛选出多重耐药菌感染者,并分析结果。结果该院调查期间收治恶性肿瘤患者2 937例,发生医院感染269例,其中发生多重耐药菌感染的恶性肿瘤患者44例,占恶性肿瘤患者医院感染的16.4%,所患肿瘤主要以肺癌为主,感染以肺炎为主,占43.2%;分离出多重耐药株61株,其中革兰阴性杆菌42株,革兰阳性球菌19株,排在前5位的细菌依次为大肠埃希菌、肺炎克雷伯菌、铜绿假单胞菌、凝固酶阴性葡萄球菌和金葡菌。所分离细菌对常用抗菌药物有很高耐药性;由多重耐药菌感染导致的病死率达65.9%。结论恶性肿瘤患者多重耐药菌感染情况严峻,控制感染发生的关键在于加强高危人群的监控和病原菌耐药性监测,减少抗菌药物不合理应用。Objective To survey the multi-drug resistant bacterial hospital infections in the patients with malignant tumor so as to support rational use of antibiotics in clinical practice and control of multi-drug resistant infections. Methods The clinical data of nosocomial infections were reviewed retrospectively in the patients with malignant tumor treated in our hospital from January 2007 to December 2010. Multi-drug resistant bacterial infections were identified for further analysis. Results A total of 2 937 patients with malignant tumor were surveyed. Nosocomial infection was found in 269 patients. Multi-drug resistant bacterial infection was identified in 44 patients (16.4%, 44/269). Most of the patients had lung cancer. The infection was mainly pneumonia (43.2 %). A total of 61 multi drug resistant bacterial strains were isolated, including gram-negative bacillus (42 strains) and gram-positive coccus (19 strains). The top five bacterial pathogens were E. coli, K. pneurnoniae, P. aeruginosa, eoagu- lase-negative Staphylococcus, and Staphylococcus aureus. These isolates were highly resistant to the commonly used antimicro bial agents. The mortality due to multi-drug resistant infection was 65.9%. Conclusions The multi-drug resistant bacterial hospi- tal infection is serious in the patients with malignant tumor. The key to control of multi-drug resistant bacterial infection is to strengthen monitoring of the patients at risk and antibiotic resistance, and reduce the unreasonable antibiotic use as far as possible.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.249